V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220021406 | 220007380 | 1.59 | 78.8 | Curative (C) | null | 2014-03-02 | Rituximab | N | N | 220028490 | RITUXIMAB |
| 220021407 | 220007399 | 1.66 | 84.1 | Curative (C) | 2017-06-10 | 2017-06-10 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028542 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021408 | 220007432 | 1.5 | null | Curative (C) | 2013-12-10 | 2015-05-21 | Dasatinib | 1 | N | 220028709 | DASATINIB |
| 220021409 | 220014106 | 1.64 | 81 | Curative (C) | 2018-06-12 | 2018-06-12 | AML 18 TRIAL | 1 | N | 220028812 | AML18 TRIAL |
| 220021410 | 220007473 | null | null | Curative (C) | 2015-03-18 | 2016-03-28 | Dasatinib | 02 | N | 220028868 | DASATINIB |
| 220021411 | 220007479 | 1.88 | 60 | Curative (C) | 2016-09-08 | 2016-09-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028892 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021412 | 220007484 | 1.72 | 90.35 | Curative (C) | 2016-12-31 | 2017-01-01 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220028901 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021414 | 220007510 | 1.64 | 43.4 | Curative (C) | 2015-02-22 | 2015-02-23 | Triple Intrathecal | N | N | 220028990 | TRIPLE INTRATHECAL |
| 220021415 | 220007516 | 0 | null | Curative (C) | 2015-06-09 | 2015-06-16 | Triple Intrathecal | N | N | 220028997 | TRIPLE INTRATHECAL |
| 220021416 | 220007517 | null | 46.3 | Curative (C) | null | 2018-03-26 | Methotrexate intrathecal | null | N | 220028999 | METHOTREXATE INTRATHECAL |
| 220021417 | 220019715 | 1.6 | null | Disease modification (D) | null | 2018-06-21 | AML Int Guide ADE 8+3+5 (2) | N | null | 220029118 | ADE |
| 220021419 | 220007555 | null | 60 | Curative (C) | 2016-01-27 | 2016-02-03 | Triple / Double Intrathecal Therapy | N | N | 220029134 | TRIPLE INTRATHECAL |
| 220021421 | 220007595 | 0 | 72.5 | Curative (C) | 2018-12-14 | 2019-04-09 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220029327 | IDARUBICIN + TRETINOIN |
| 220021423 | 220017746 | 0 | 70.4 | Curative (C) | 2014-07-06 | 2014-07-11 | IDARUBICIN + TRETINOIN | 02 | Y | 220029445 | IDARUBICIN + TRETINOIN |
| 220021424 | 220007636 | 1.76 | 87.3 | Curative (C) | 2013-08-09 | 2017-05-06 | IDARUBICIN + TRETINOIN | N | N | 220029467 | IDARUBICIN + TRETINOIN |
| 220021425 | 220007639 | 1.79 | 61.5 | Curative (C) | 2015-12-29 | 2016-01-04 | IDARUBICIN + TRETINOIN | 02 | N | 220029470 | IDARUBICIN + TRETINOIN |
| 220021426 | 220007652 | 1.91 | null | Curative (C) | 2014-07-20 | 2014-07-23 | FLAG | 02 | N | 220029514 | FLAG |
| 220021427 | 220007659 | null | 59.4 | Curative (C) | 2016-08-06 | 2016-08-06 | AML16 DA 3+8 | null | null | 220029559 | AML16 TRIAL |
| 220021428 | 220017759 | null | 74.7 | Curative (C) | 2014-06-16 | 2014-09-04 | Triple / Double Intrathecal Therapy | N | N | 220029586 | TRIPLE INTRATHECAL |
| 220021429 | 220014222 | 1.94 | 59 | Curative (C) | null | 2017-02-18 | Cyclophosphamide+Fludara+TBI Allo | null | N | 220029599 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220021430 | 220007691 | 1.75 | 88.6 | Curative (C) | 2014-02-03 | 2014-02-09 | ATG + Busulfan + Fludarabine | N | N | 220029667 | ATG + BUSULFAN + FLUDARABINE |
| 220021431 | 220007694 | 1.9 | 71.5 | Curative (C) | 2015-02-14 | 2015-02-16 | IDARUBICIN + TRETINOIN | 2 | N | 220029672 | IDARUBICIN + TRETINOIN |
| 220021432 | 220007706 | 1.6 | 60 | Curative (C) | 2018-07-30 | 2018-08-07 | AML16 Azacitidine | Y | N | 220029704 | AML16 TRIAL |
| 220021433 | 220007716 | 1.78 | 83 | Curative (C) | 2018-08-29 | 2018-09-05 | FLAG | N | N | 220029746 | FLAG |
| 220021434 | 220007719 | 0 | 104.2 | Curative (C) | 2015-09-18 | 2015-09-18 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | N | 220029749 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220021435 | 220007746 | 1.67 | 75 | Curative (C) | 2016-02-01 | 2016-05-26 | Triple / Double Intrathecal Therapy | N | N | 220029817 | TRIPLE INTRATHECAL |
| 220021437 | 220007805 | null | 83.7 | Curative (C) | null | 2017-08-05 | ATG + Busulfan + Fludarabine | N | null | 220030047 | ATG + BUSULFAN + FLUDARABINE |
| 220021438 | 220014301 | 1.74 | 7.1 | Curative (C) | 2018-07-28 | 2018-08-28 | BOSUTINIB | 02 | N | 220030066 | BOSUTINIB |
| 220021439 | 220007824 | null | null | Curative (C) | 2017-09-09 | 2017-09-28 | BOSUTINIB | N | N | 220030093 | BOSUTINIB |
| 220021440 | 220014309 | 1.66 | 65 | Curative (C) | 2014-06-24 | 2014-07-02 | FLAG | N | N | 220030109 | FLAG |
| 220021441 | 220019770 | 1.57 | 56 | Curative (C) | 2016-09-10 | 2016-09-20 | ATG + Busulfan + Fludarabine | 02 | N | 220030114 | ATG + BUSULFAN + FLUDARABINE |
| 220021442 | 220007839 | 0 | 0 | Curative (C) | 2015-12-24 | 2016-01-02 | AML Int Guide ADE 10+3+5 (1) | 02 | N | 220030144 | ADE |
| 220021443 | 220007847 | 0 | 95.2 | Curative (C) | 2018-12-21 | 2019-01-31 | Triple / Double Intrathecal Therapy | null | N | 220030148 | TRIPLE INTRATHECAL |
| 220021444 | 220007858 | null | 94.6 | Curative (C) | null | 2017-03-10 | FLAG | 02 | N | 220030182 | FLAG |
| 220021445 | 220007874 | 1.56 | 51.9 | Curative (C) | 2018-01-10 | 2018-01-11 | RUXOLITINIB | N | null | 220030225 | RUXOLITINIB |
| 220021446 | 220007881 | 1.58 | null | Disease modification (D) | null | 2017-07-14 | AML Int Guide ADE 8+3+5 (2) | N | null | 220030233 | ADE |
| 220021448 | 220014336 | null | 71 | Disease modification (D) | 2016-09-26 | 2016-09-27 | CYCLOPHOSPHAMIDE + FLUDARABINE | null | N | 220030293 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220021449 | 220007906 | 1.67 | null | Curative (C) | 2017-12-05 | 2017-12-05 | Cyclophosphamide TBI Allograft | N | N | 220030299 | CYCLOPHOSPHAMIDE |
| 220021450 | 220007929 | null | 78 | Curative (C) | 2014-03-22 | 2014-03-23 | Methotrexate intrathecal | 02 | N | 220030353 | METHOTREXATE INTRATHECAL |
| 220021451 | 220007945 | 1.82 | 88.8 | Disease modification (D) | 2018-02-22 | 2018-02-22 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220030435 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220021452 | 220007961 | 1.67 | null | null | 2015-07-02 | 2015-07-12 | BOSUTINIB | N | null | 220030471 | BOSUTINIB |
| 220021453 | 220017839 | 1.67 | 85 | Curative (C) | 2017-09-21 | 2018-08-30 | Triple Intrathecal | N | N | 220030475 | TRIPLE INTRATHECAL |
| 220021454 | 220007969 | 1.71 | 70.95 | Curative (C) | 2015-06-10 | 2018-03-02 | IDARUBICIN + TRETINOIN | null | null | 220030478 | IDARUBICIN + TRETINOIN |
| 220021455 | 220007980 | 1.75 | 79 | Curative (C) | 2015-08-03 | 2015-08-05 | RUXOLITINIB | 2 | N | 220030495 | RUXOLITINIB |
| 220021456 | 220020917 | 1.49 | 75 | Curative (C) | 2014-05-17 | 2014-05-17 | CYCLOPHOSPHAMIDE | N | N | 220030497 | CYCLOPHOSPHAMIDE |
| 220021457 | 220007993 | 1.71 | 109 | Palliative (P) | 2014-07-17 | 2014-07-20 | Cyclophosphamide+Fludara+TBI Allo | 2 | N | 220030524 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220021458 | 220017848 | null | 85 | Disease modification (D) | null | 2015-02-26 | Triple / Double Intrathecal Therapy | null | null | 220030530 | TRIPLE INTRATHECAL |
| 220021459 | 220008001 | 1.6 | 67.8 | Curative (C) | null | 2016-09-01 | FLAG | N | N | 220030535 | FLAG |
| 220021460 | 220008007 | 1.69 | 76 | Curative (C) | 2016-05-29 | 2016-07-21 | BOSUTINIB | 02 | N | 220030541 | BOSUTINIB |
| 220021461 | 220008017 | null | 33 | Curative (C) | 2017-11-26 | 2017-12-05 | FLAG | N | N | 220030565 | FLAG |